Regencell Bioscience Holdings Limited (RGC)
RGC Stock Price Chart
Explore Regencell Bioscience Holdings Limited interactive price chart. Choose custom timeframes to analyze RGC price movements and trends.
RGC Company Profile
Discover essential business fundamentals and corporate details for Regencell Bioscience Holdings Limited (RGC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
16 Jul 2021
Employees
12.00
CEO
Yat-Gai Au
Description
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC Financial Timeline
Browse a chronological timeline of Regencell Bioscience Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 16 Jul 2025
Stock split effective on 16 Jun 2025
Shares were split 38 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Jan 2025
EPS came in at -$0.14 .
Earnings released on 25 Oct 2024
EPS came in at -$0.00 .
Earnings released on 31 Mar 2024
EPS came in at $0.00 .
Earnings released on 26 Jan 2024
EPS came in at $0.00 .
Earnings released on 27 Oct 2023
EPS came in at -$0.01 .
Earnings released on 30 Sept 2023
EPS came in at $0.00 .
Earnings released on 31 Mar 2023
EPS came in at $0.00 .
Earnings released on 30 Jan 2023
EPS came in at -$0.01 .
Earnings released on 31 Oct 2022
EPS came in at -$0.01 , while revenue for the quarter reached -$2.34B .
Earnings released on 30 Sept 2022
EPS came in at $0.00 .
Earnings released on 31 Mar 2022
EPS came in at $0.00 .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 .
Earnings released on 29 Oct 2021
EPS came in at $0.00 , while revenue for the quarter reached -$2.34B .
Earnings released on 30 Sept 2021
EPS came in at $0.00 .
Earnings released on 31 Mar 2021
EPS came in at $0.00 .
Earnings released on 31 Dec 2020
EPS came in at $0.00 .
Earnings released on 30 Sept 2020
EPS came in at $0.00 .
RGC Stock Performance
Access detailed RGC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.